Patents by Inventor Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF REDUCING INTRAOCULAR PRESSURE IN HUMANS
    Publication number: 20130217643
    Abstract: Provided herein are compounds of Formula I, compositions comprising an effective amount of a compound of Formula I, and methods for reducing intraocular pressure comprising administering an effective amount of compounds of Formula I to a subject in need thereof.
    Type: Application
    Filed: April 3, 2013
    Publication date: August 22, 2013
    Applicant: INOTEK PHARMACEUTICALS CORPORATION
    Inventor: INOTEK PHARMACEUTICALS CORPORATION
  • ANHYDROUS POLYMORPHS OF [(2R,3S,4R,5R)-5-(6-(CYCLOPENTYLAMINO)-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)} METHYL NITRATE AND PROCESSES OF PREPARATION THEREOF
    Publication number: 20130196940
    Abstract: The present invention provides novel anhydrous polymorph forms of 2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl nitrate (Compound A). The present invention also provides processes for preparation of the anhydrous polymorphic forms of compound A.
    Type: Application
    Filed: January 25, 2013
    Publication date: August 1, 2013
    Applicant: INOTEK PHARMACEUTICALS CORPORATION
    Inventor: Inotek Pharmaceuticals Corporation